# Kiora Pharmaceuticals Inc: filings

KPRX · Nasdaq · CIK 1372514 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kprx.md) · [Financials](/companies/kprx/financials.md) · [Filings](/companies/kprx/filings.md) · [Insiders](/companies/kprx/insiders.md)

## Reports and events: 266 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 370, 8-K 155, CORRESP 40, 10-Q 35, 3 33, SC 13G 23, UPLOAD 22, S-1/A 21, SC 13G/A 20, D 17, EFFECT 15, SC 13D/A 14, DEF 14A 13, 10-K 12, S-8 12, SCHEDULE 13G/A 12, 424B3 9, FWP 9, DEFA14A 8, PRE 14A 8, S-1 8, S-3 8, 424B5 6, SCHEDULE 13G 5, 424B4 4, CERTNAS 4, CT ORDER 4, S-3/A 4, SC 13D 4, 4/A 3, 424B1 2, 8-A12B 2, 8-K/A 2, POS EX 2, 10-K/A 1, 10-Q/A 1, 144 1, 25-NSE 1, 8-A12B/A 1, 8-A12G 1, ARS 1, DRS 1, DRS/A 1, DRSLTR 1, NT 10-K 1, NT 10-Q 1, REGDEX 1, RW 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:03 ET | [8-K](/filings/0001372514-26-000088.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-26-000088 |
| 2026-09-08 | 07:05 ET | [8-K](/filings/0001372514-26-000079.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-26-000079 |
| 2026-08-19 | 07:01 ET | [8-K](/filings/0001372514-26-000077.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-26-000077 |
| 2026-08-07 | 07:03 ET | [8-K](/filings/0001372514-26-000075.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-26-000075 |
| 2026-08-07 | 07:02 ET | [10-Q](/filings/0001372514-26-000074.md) | Quarterly report, period 2026-06-30 | 0001372514-26-000074 |
| 2026-06-18 | 07:02 ET | [8-K](/filings/0001372514-26-000063.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-26-000063 |
| 2026-06-11 | 18:39 ET | [8-K](/filings/0001372514-26-000059.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001372514-26-000059 |
| 2026-05-08 | 07:07 ET | [8-K](/filings/0001372514-26-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-26-000048 |
| 2026-05-08 | 07:06 ET | [10-Q](/filings/0001372514-26-000047.md) | Quarterly report, period 2026-03-31 | 0001372514-26-000047 |
| 2026-04-30 | 17:11 ET | [DEF 14A](/filings/0001372514-26-000040.md) | Proxy statement, period 2026-04-16 | 0001372514-26-000040 |
| 2026-04-07 | 07:01 ET | [8-K](/filings/0001372514-26-000036.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-26-000036 |
| 2026-04-02 | 16:44 ET | [8-K](/filings/0001372514-26-000028.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-26-000028 |
| 2026-03-25 | 07:03 ET | [8-K](/filings/0001372514-26-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-26-000025 |
| 2026-03-25 | 07:01 ET | [10-K](/filings/0001372514-26-000024.md) | Annual report, period 2025-12-31 | 0001372514-26-000024 |
| 2025-11-07 | 06:02 ET | [8-K](/filings/0001372514-25-000079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-25-000079 |
| 2025-11-07 | 06:01 ET | [10-Q](/filings/0001372514-25-000078.md) | Quarterly report, period 2025-09-30 | 0001372514-25-000078 |
| 2025-08-13 | 18:00 ET | [8-K](/filings/0001372514-25-000068.md) | 7.01 Regulation FD disclosure | 0001372514-25-000068 |
| 2025-08-08 | 07:14 ET | [8-K](/filings/0001372514-25-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-25-000064 |
| 2025-08-08 | 07:01 ET | [10-Q](/filings/0001372514-25-000061.md) | Quarterly report, period 2025-06-30 | 0001372514-25-000061 |
| 2025-06-04 | 14:34 ET | [8-K](/filings/0001372514-25-000053.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001372514-25-000053 |
| 2025-06-03 | 07:00 ET | [8-K](/filings/0001372514-25-000050.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-25-000050 |
| 2025-05-09 | 07:02 ET | [8-K](/filings/0001372514-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-25-000045 |
| 2025-05-09 | 06:59 ET | [10-Q](/filings/0001372514-25-000044.md) | Quarterly report, period 2025-03-31 | 0001372514-25-000044 |
| 2025-04-30 | 10:00 ET | [DEF 14A](/filings/0001372514-25-000038.md) | Proxy statement, period 2025-04-16 | 0001372514-25-000038 |
| 2025-03-25 | 07:00 ET | [8-K](/filings/0001372514-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-25-000014 |
| 2025-03-25 | 06:55 ET | [10-K](/filings/0001372514-25-000012.md) | Annual report, period 2024-12-31 | 0001372514-25-000012 |
| 2025-01-15 | 17:22 ET | [8-K](/filings/0001372514-25-000003.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001372514-25-000003 |
| 2024-11-08 | 07:01 ET | [8-K](/filings/0001372514-24-000121.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-24-000121 |
| 2024-11-08 | 07:00 ET | [10-Q](/filings/0001372514-24-000120.md) | Quarterly report, period 2024-09-30 | 0001372514-24-000120 |
| 2024-10-29 | 07:00 ET | [8-K](/filings/0001372514-24-000117.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-24-000117 |
| 2024-08-09 | 07:01 ET | [8-K](/filings/0001372514-24-000105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-24-000105 |
| 2024-08-09 | 07:01 ET | [10-Q](/filings/0001372514-24-000104.md) | Quarterly report, period 2024-06-30 | 0001372514-24-000104 |
| 2024-07-30 | 07:02 ET | [8-K](/filings/0001372514-24-000099.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-24-000099 |
| 2024-07-01 | 07:00 ET | [8-K](/filings/0001372514-24-000068.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-24-000068 |
| 2024-06-07 | 07:02 ET | [8-K](/filings/0001372514-24-000057.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-24-000057 |
| 2024-05-10 | 07:01 ET | [8-K](/filings/0001372514-24-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-24-000054 |
| 2024-05-10 | 07:00 ET | [10-Q](/filings/0001372514-24-000053.md) | Quarterly report, period 2024-03-31 | 0001372514-24-000053 |
| 2024-05-03 | 17:56 ET | [8-K](/filings/0001372514-24-000039.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001372514-24-000039 |
| 2024-03-25 | 16:32 ET | [DEF 14A](/filings/0001372514-24-000030.md) | Proxy statement, period 2024-05-01 | 0001372514-24-000030 |
| 2024-03-25 | 07:03 ET | [8-K](/filings/0001372514-24-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-24-000027 |
| 2024-03-25 | 07:01 ET | [10-K](/filings/0001372514-24-000026.md) | Annual report, period 2023-12-31 | 0001372514-24-000026 |
| 2024-02-12 | 17:23 ET | [8-K](/filings/0001372514-24-000013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-24-000013 |
| 2024-02-01 | 07:01 ET | [8-K](/filings/0001372514-24-000010.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-24-000010 |
| 2024-01-31 | 17:14 ET | [8-K](/filings/0001372514-24-000007.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-24-000007 |
| 2024-01-16 | 17:16 ET | [8-K](/filings/0001372514-24-000002.md) | 3.01 Delisting notice | 0001372514-24-000002 |
| 2023-11-09 | 07:02 ET | [8-K](/filings/0001372514-23-000160.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-23-000160 |
| 2023-11-09 | 07:01 ET | [8-K](/filings/0001372514-23-000159.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-23-000159 |
| 2023-11-09 | 07:00 ET | [10-Q](/filings/0001372514-23-000158.md) | Quarterly report, period 2023-09-30 | 0001372514-23-000158 |
| 2023-11-06 | 06:05 ET | [8-K](/filings/0001372514-23-000154.md) | 9.01 Financial statements and exhibits | 0001372514-23-000154 |
| 2023-09-28 | 19:06 ET | [8-K](/filings/0001372514-23-000132.md) | 5.07 Shareholder vote results | 0001372514-23-000132 |

Page 1 of 6. [Older](/companies/kprx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:04 ET. No prices; not investment advice.